TL011 in Severe, Active Rheumatoid Arthritis Patients
Condition(s):Rheumatoid ArthritisLast Updated:October 4, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Rheumatoid ArthritisLast Updated:October 4, 2021Completed
Condition(s):FIGO Stage III and IV Ovarian Cancer; FIGO Stage III and IV Fallopian Tube Cancer; FIGO Stage III Primary Peritoneal CancerLast Updated:October 13, 2023Completed
Condition(s):Total Hip Arthroplasty; Muscle InjuryLast Updated:September 21, 2015Completed
Condition(s):Follicular LymphomaLast Updated:August 2, 2012Unknown status
Condition(s):Rheumatoid ArthritisLast Updated:July 20, 2016Terminated
Condition(s):Hydatidiform MoleLast Updated:April 17, 2020Completed
Condition(s):Schistosoma Haematobium; Schistosoma MansoniLast Updated:April 5, 2021Completed
Condition(s):Frequently Relapsing Nephrotic Syndrome; Steroid-Dependent Nephrotic SyndromeLast Updated:December 29, 2020Withdrawn
Condition(s):Rheumatoid ArthritisLast Updated:May 14, 2020Completed
Condition(s):Arthritis, RheumatoidLast Updated:November 6, 2017Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.